Abstract
C3H/He mice bearing SCC VII tumors received 5‐bromo‐2′‐deoxyuridine (BrdU) continuously for 5 days via implanted mini‐osmotic pumps to label all proliferating (P) cells. The mice then received one of six different DNA‐damaging agents with or without mild temperature hyperthermia (40°C, 30 min, MTH). These agents were adriamycin (ADM), mitomycin C (MMC), cyclophosphamide (CPA), bleomycin (BLM), cisplatin (CDDP), and tirapazamine (TPZ). After the drug treatment, the tumor‐bearing mice were irradiated with a series of doses of γ‐rays. Immediately after irradiation, the tumors were excised, minced and trypsinized. The tumor cell suspensions thus obtained were incubated with cytochalasin‐B (a cytokinesis blocker), and the micronucleus (MN) frequency in cells without BrdU labeling (=quiescent (Q) cells) was determined using immunofluorescence staining for BrdU. The MN frequency in the total (P+Q) tumor cells was determined from the tumors that had not been pretreated with BrdU. MTH significantly increased the MN frequency of total cells in tumors irradiated with γ‐rays combined with CPA, BLM, CDDP or TPZ, and that of Q cells in tumors irradiated with γ‐rays combined with BLM or TPZ. The sensitivity difference in the MN frequency between total and Q tumor cells was significantly decreased by the combination with TPZ. TPZ combined with radiotherapy and TPZ combined with thermo‐radiotherapy at mild temperatures appear to be promising modalities for sensitizing tumor cells in vivo, including Q tumor cells.
Keywords: Quiescent cell, Mild temperature hyperthermia, γ‐Ray, DNA‐damaging agent, Tirapazamine
Full Text
The Full Text of this article is available as a PDF (81.7 KB).
REFERENCES
- 1. ) Overgaard , J. , Gonzales , D. G. , Hulshur , M. C. C. M. , Archangeli , G. , Dahl , O. , Mella , O. and Benzen , S. M.Randomized trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma . Lancet , 345 , 540 – 543 ( 1995. ). [DOI] [PubMed] [Google Scholar]
- 2. ) Vaupel , P. W.The influence of tumor blood flow and microenvironmental factors on the efficacy of radiation, drugs and localized hyperthermia . Klin. Pediatr. , 209 , 243 – 249 ( 1997. ). [DOI] [PubMed] [Google Scholar]
- 3. ) Dewey , W. C.Arrhenius relationship from the molecule and cell to clinic . Int. J. Hyperthermia , 10 , 457 – 483 ( 1994. ). [DOI] [PubMed] [Google Scholar]
- 4. ) Oleson , J. R.Hyperthermia from the clinic to the laboratory: hypothesis (Eugene Robinson Special Lecture) . Int. J. Hyperthermia , 11 , 315 – 322 ( 1995. ). [DOI] [PubMed] [Google Scholar]
- 5. ) Griffin , R. J. , Okajima , K. , Ogawa , A. and Song , C. W.Radiosensitization of two murine tumours with mild temperature hyperthermia and carbogen breathing . Int. J. Radiat. Biol. , 75 , 1299 – 1306 ( 1999. ). [DOI] [PubMed] [Google Scholar]
- 6. ) Urano , M. , Kuroda , M. and Nishimura , Y.Invited review: for the clinical application of thermochemotherapy given at mild temperatures . Int. J. Hyperthermia , 15 , 79 – 107 ( 1999. ). [DOI] [PubMed] [Google Scholar]
- 7. ) Brown , J. M. and Giaccia , A. J.The unique physiology of solid tumors: opportunities (and problems) for cancer therapy . Cancer Res. , 58 , 1408 – 1416 ( 1998. ). [PubMed] [Google Scholar]
- 8. ) Rauth , A. M. , Melo , T. and Misra , V.Bioreductive therapies: an overview of drugs and their mechanisms of action . Int. J. Radiat. Oncol. Biol. Phys. , 42 , 755 – 762 ( 1998. ). [DOI] [PubMed] [Google Scholar]
- 9. ) Zeman , E. M. , Brown , J. M. , Lemmon , M. J. , Hirst , V. K. and Lee , W. W.SR‐4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells . Int. J. Radiat. Oncol. Biol. Phys. , 12 , 1239 – 1242 ( 1986. ). [DOI] [PubMed] [Google Scholar]
- 10. ) Masunaga , S. , Ono , K. and Abe , M.Potentially lethal damage repair by quiescent cells in murine solid tumors . Int. J. Radiat. Oncol. Biol. Phys. , 22 , 973 – 978 ( 1992. ). [DOI] [PubMed] [Google Scholar]
- 11. ) Seng , F. and Ley , K.Simple synthesis of 3‐amino‐1,2,4‐benzotriazine‐1,4‐dioxide . Angew. Chem. Int. Ed. Engl. , 11 , 1009 – 1010 ( 1972. ). [Google Scholar]
- 12. ) Nishimura , Y. , Ono , K. , Hiraoka , M. , Masunaga , S. , Jo , S. , Shibamoto , Y. , Sasai , K. , Abe , M. , Iga , K. and Ogawa , Y.Treatment of murine SCC VII tumors with localized hyperthermia and temperature‐sensitive liposomes containing cisplatin . Radiat. Res. , 122 , 161 – 167 ( 1990. ). [PubMed] [Google Scholar]
- 13. ) Ono , K. , Wandl , E. O. , Tsutsui , K. , Sasai , K. and Abe , M.The correlation between cell survival curve and dose response curve of micronucleus (MN) frequency . Strahlenther. Onkol. , 165 , 824 – 827 ( 1989. ). [PubMed] [Google Scholar]
- 14. ) Prados , M. D. , Scott , C. B. , Rotman , M. , Rubin , P. , Murray , K. , Sause , W. , Asbell , S. , Comis , R. , Curran , W. , Nelson , J. , Daxis , R. L. , Levin , V. A. , Lamborn , K. and Phillips , T. L.Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma . Int. J. Radiat. Oncol. Biol. Phys. , 40 , 653 – 659 ( 1998. ). [DOI] [PubMed] [Google Scholar]
- 15. ) Fenech , M. and Morley , A. A.Measurement of micronuclei in lymphocytes . Mutat. Res. , 147 , 29 – 36 ( 1985. ). [DOI] [PubMed] [Google Scholar]
- 16. ) Hall , E. J.Chemotherapeutic agents from the perspective of the radiation biologist . In “Radiobiology for the Radiologist, Fourth Edition ,” ed. Hall E. J. , pp. 289 – 309 ( 1994. ). J. B. Lippincott Co. , Philadelphia . [Google Scholar]
- 17. ) Masunaga , S. , Ono , K. , Akaboshi , M. , Kawai , K. , Suzuki , M. , Kinashi , Y. and Takagaki , M.Augmentation in chemosensitivity of intratumor quiescent cells by combined treatment with nicotinamide and mild hyperthermia . Jpn. J. Cancer. Res. , 88 , 770 – 777 ( 1997. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. ) Masunaga , S. , Ono , K. , Hori , H. , Kinashi , Y. , Suzuki , M. , Takagaki , M. , Kasai , S. , Nagasawa , H. and Uto , Y.Modification of tirapazamine‐induced cytotoxicity in combination with mild hyperthermia and/or nicotinamide: reference to effect on quiescent tumour cells . Int. J. Hyperthermia , 15 , 7 – 16 ( 1999. ). [DOI] [PubMed] [Google Scholar]
- 19. ) Masunaga , S. , Ono , K. and Abe , M.The detection and modification of the hypoxic fraction in quiescent cell populations in murine solid tumours . Br. J. Radiol. , 66 , 918 – 926 ( 1993. ). [DOI] [PubMed] [Google Scholar]
- 20. ) Masunaga , S. , Ono , K. , Suzuki , M. , Kinashi , Y. , Takagaki , M. and Akaboshi , M.Alteration in the hypoxic fraction of quiescent cell populations by hyperthermia at mild temperatures . Int. J. Hyperthermia , 13 , 401 – 411 ( 1997. ). [DOI] [PubMed] [Google Scholar]
- 21. ) Wouters , B. G. and Brown , J. M.Cells at intermediate oxygen levels can be more important than the ‘hypoxic fraction’ in determining tumor response to fractionated radiotherapy . Radiat. Res. , 147 , 541 – 550 ( 1997. ). [PubMed] [Google Scholar]